|
CA-MRSA |
HA-MRSA |
At-Risk Populations |
Children, prisoners, homeless, homosexual males, soldiers, intravenous drug users, general population |
Healthcare facility residents, diabetics, hospitalized patients, ICU patients |
SCCmec subtype |
IV, V |
I, II, III |
Resistant against |
Beta-lactam drugs (oxacillin, penicillin), erythromycin |
Usually multidrug resistance, tend to be susceptible to TMP-SMX, macrolides, tetracyclines |
PVL toxin |
Present in >95% of cases |
Rare (5%) |
Clinical Affiliation |
Post-influenza necrotizing pneumonia, osteomyelitis |
Nosocomial pneumonia, Catheter-acquired UTI, Bacteremia |
Discovered |
1980s |
1961 |